Cargando…

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Detalles Bibliográficos
Autores principales: Monschein, Tobias, Dekany, Sarinah, Zrzavy, Tobias, Ponleitner, Markus, Altmann, Patrick, Bsteh, Gabriel, Kornek, Barbara, Rommer, Paulus, Enzinger, Christian, Di Pauli, Franziska, Kraus, Jörg, Berger, Thomas, Leutmezer, Fritz, Guger, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344974/
https://www.ncbi.nlm.nih.gov/pubmed/37272963
http://dx.doi.org/10.1007/s00415-023-11784-1
_version_ 1785072981329838080
author Monschein, Tobias
Dekany, Sarinah
Zrzavy, Tobias
Ponleitner, Markus
Altmann, Patrick
Bsteh, Gabriel
Kornek, Barbara
Rommer, Paulus
Enzinger, Christian
Di Pauli, Franziska
Kraus, Jörg
Berger, Thomas
Leutmezer, Fritz
Guger, Michael
author_facet Monschein, Tobias
Dekany, Sarinah
Zrzavy, Tobias
Ponleitner, Markus
Altmann, Patrick
Bsteh, Gabriel
Kornek, Barbara
Rommer, Paulus
Enzinger, Christian
Di Pauli, Franziska
Kraus, Jörg
Berger, Thomas
Leutmezer, Fritz
Guger, Michael
author_sort Monschein, Tobias
collection PubMed
description
format Online
Article
Text
id pubmed-10344974
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103449742023-07-15 Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR) Monschein, Tobias Dekany, Sarinah Zrzavy, Tobias Ponleitner, Markus Altmann, Patrick Bsteh, Gabriel Kornek, Barbara Rommer, Paulus Enzinger, Christian Di Pauli, Franziska Kraus, Jörg Berger, Thomas Leutmezer, Fritz Guger, Michael J Neurol Correction Springer Berlin Heidelberg 2023-06-05 2023 /pmc/articles/PMC10344974/ /pubmed/37272963 http://dx.doi.org/10.1007/s00415-023-11784-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Monschein, Tobias
Dekany, Sarinah
Zrzavy, Tobias
Ponleitner, Markus
Altmann, Patrick
Bsteh, Gabriel
Kornek, Barbara
Rommer, Paulus
Enzinger, Christian
Di Pauli, Franziska
Kraus, Jörg
Berger, Thomas
Leutmezer, Fritz
Guger, Michael
Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
title Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
title_full Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
title_fullStr Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
title_full_unstemmed Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
title_short Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
title_sort correction: real-world use of natalizumab in austria: data from the austrian multiple sclerosis treatment registry (amstr)
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344974/
https://www.ncbi.nlm.nih.gov/pubmed/37272963
http://dx.doi.org/10.1007/s00415-023-11784-1
work_keys_str_mv AT monscheintobias correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT dekanysarinah correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT zrzavytobias correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT ponleitnermarkus correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT altmannpatrick correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT bstehgabriel correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT kornekbarbara correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT rommerpaulus correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT enzingerchristian correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT dipaulifranziska correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT krausjorg correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT bergerthomas correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT leutmezerfritz correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT gugermichael correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr
AT correctionrealworlduseofnatalizumabinaustriadatafromtheaustrianmultiplesclerosistreatmentregistryamstr